Related Experiment Video
Updated: May 1, 2026

05:01
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
3.4K
Dual-Network Cross-Learning for Metabolite-Disease Association Prediction
IEEE Transactions on Computational Biology and Bioinformatics
|August 14, 2025
Summary
This study introduces DCMDA, a novel deep learning model for predicting metabolite-disease associations. DCMDA effectively integrates metabolic and disease features, improving disease diagnosis and treatment strategies.
Area of Science:
- Biomedical Informatics
- Computational Biology
- Metabolomics
Background:
- Metabolites are increasingly linked to human diseases, offering potential for diagnosis and treatment.
- Current deep learning methods for metabolite-disease association prediction face challenges in feature integration and graph enrichment.
Purpose of the Study:
- To develop an advanced deep learning model, DCMDA, for accurate prediction of metabolite-disease associations.
- To enhance the integration of metabolic and disease features for improved predictive performance.
Main Methods:
- Constructed a heterogeneous network by integrating similarity and association networks.
- Employed non-negative matrix factorization and graph autoencoders for feature extraction.
- Utilized a Cross-Attention mechanism for feature fusion to obtain deep metabolite and disease representations.
Main Results:
- DCMDA achieved high predictive accuracy in 5-fold cross-validation.
- Demonstrated superior performance compared to existing state-of-the-art prediction methods.
- Achieved an Area Under the Receiver Operating Characteristic Curve (AUC) of 97.8% and an Area Under the Precision-Recall Curve (AUPR) of 97.9%.
Conclusions:
- DCMDA effectively addresses limitations in current metabolite-disease association prediction models.
- The proposed Dual-network Cross-learning approach offers a robust framework for uncovering complex metabolite-disease relationships.
- This model holds significant potential for advancing disease diagnosis and therapeutic strategies.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.9K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Investigation of Disease Outbreaks
74
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
74

